AI assistant
NANOVIRICIDES, INC. — Director's Dealing 2013
Sep 16, 2013
34915_dirs_2013-09-16_98a50e05-ed23-488d-8b27-28da486d7572.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2013-09-11
Reporting Person: BONIUK MILTON (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-12 | Common Stock, par value $0.001 per share | P | 571428 | $3.50 | Acquired | 658571 | Direct |
| 2013-09-12 | Common Stock, par value $0.001 per share | P | 285714 | $3.50 | Acquired | 476191 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-11 | Common Stock Warrants | $5.25 | A | 571428 | Acquired | 2018-09-12 | Common Stock (571428) | Direct |
| 2013-09-11 | Common Stock Warrants | $5.25 | A | 285714 | Acquired | 2018-09-12 | Common Stock (285714) | Indirect |
Footnotes
F1: Includes 571,428 shares of common stock held in the name of the Reporting Person and his wife, Laurie Boniuk.
F2: Includes 285,714 shares of common stock held in the name of Boniuk Investments Ltd.
F3: Does not include 100 shares of common stock issuable upon exercise of warrants held by the Reporting Person that are currently exercisable.
F4: Does not include an indeterminate number of shares of common stock issuable upon exercise of debentures held by Boniuk Investments Ltd. that are currently exercisable.
F5: The warrants are presently exercisable.